Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Buse

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Diabetes Care|April 6, 1999
Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapyJ B Buse
Primary Care|October 16, 1999
The use of insulin alone and in combination with oral agents in type 2 diabetesJ B Buse
Clinical Cornerstone|February 22, 2000
Management of glycemia in type 2 diabetesJ B Buse
Diabetologia|April 9, 2008
A dead heat: target normal glucose levels in the intensive care unit--but with cautionJ B Buse
The American Journal of Managed Care|February 24, 2001
Thiazolidinediones in the treatment of type 2 diabetes: a clinician's perspectiveJ B Buse
Postgraduate Medicine|August 12, 2009
Panel discussion on achieving glycemic controlJ B Buse, D Einhorn
The Journal of Family Practice|December 3, 1998
The case for a role for postprandial glucose monitoring in diabetes managementJ B Buse, M Hroscikoski
Vitamins and Hormones|January 1, 1985
Autoimmune endocrine diseaseJ B Buse, G S Eisenbarth
Postgraduate Medicine|August 12, 2009
Treatment of postprandial hyperglycemia in type 2 diabetesE A Fasy, J B Buse
Journal of Autoimmunity|October 1, 1988
T-cell antigen receptor alpha chain polymorphisms in insulin-dependent diabetesE Bhatia, J B Buse, R A Jackson
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Diabetes Care|April 6, 1999
Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapyJ B Buse
Primary Care|October 16, 1999
The use of insulin alone and in combination with oral agents in type 2 diabetesJ B Buse
Clinical Cornerstone|February 22, 2000
Management of glycemia in type 2 diabetesJ B Buse
Diabetologia|April 9, 2008
A dead heat: target normal glucose levels in the intensive care unit--but with cautionJ B Buse
The American Journal of Managed Care|February 24, 2001
Thiazolidinediones in the treatment of type 2 diabetes: a clinician's perspectiveJ B Buse
Postgraduate Medicine|August 12, 2009
Panel discussion on achieving glycemic controlJ B Buse, D Einhorn
The Journal of Family Practice|December 3, 1998
The case for a role for postprandial glucose monitoring in diabetes managementJ B Buse, M Hroscikoski
Vitamins and Hormones|January 1, 1985
Autoimmune endocrine diseaseJ B Buse, G S Eisenbarth
Postgraduate Medicine|August 12, 2009
Treatment of postprandial hyperglycemia in type 2 diabetesE A Fasy, J B Buse
Journal of Autoimmunity|October 1, 1988
T-cell antigen receptor alpha chain polymorphisms in insulin-dependent diabetesE Bhatia, J B Buse, R A Jackson
Pageof 5